Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1992-06-04
1993-11-09
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424451, 424457, 424464, 424468, 514849, 514853, A61K 908, A61K 920, A61K 948
Patent
active
052600734
ABSTRACT:
The present invention encompasses the novel method of using .+-.phenylpropanolamine to induce mucous secretion in the upper airways of persons afflicted with sinusitis or otitis media characterized by retention of thickened respiratory secretions. These methods comprise administering to such person a safe and effective amount of .+-.phenylpropanolamine. It also encompasses certain novel oral compositions consisting essentially of l(-)-norephedrine and a pharmaceutically-acceptable excipient base.
REFERENCES:
patent: 4083950 (1978-04-01), Duvall et al.
patent: 4619934 (1986-10-01), Sunshine et al.
patent: 4738966 (1988-04-01), Sunshine et al.
patent: 4749697 (1988-06-01), Sunshine et al.
patent: 4749711 (1988-06-01), Sunshine et al.
patent: 4749720 (1988-06-01), Sunshine et al.
patent: 4749721 (1988-06-01), Sunshine et al.
patent: 4749722 (1988-06-01), Sunshine et al.
patent: 4749723 (1988-06-01), Sunshine et al.
patent: 4818541 (1989-04-01), Sanderson
patent: 4839354 (1989-06-01), Sunshine et al.
patent: 4840962 (1989-06-01), Sunshine et al.
patent: 4894233 (1990-01-01), Sharma
Gallagher, J. T. et al., "The composition of tracheal mucus and the nervous control of its secretion in the cat," 192 Proc. R. Soc. Long. B., 49-76 (1975).
Wells, U. et al., "Lateral Nasal Gland Secretion in the Anaesthetized Dog," 374 J. Physiol., 359-374 (1986).
Phipps, R. J. et al., "Effect of Alpha-Adrenergic Stimulation on Mucus Secretion and on Ion Transport in Cat Trachea In Vitro.sup.1-3," 121 American Review of Repiratory Disease, 359-365 (1980).
Phipps, R. J. et al., "Sympathomimetic drugs stimulate the output of secretory glycoproteins from human bronchi in vitro," 63 Clinical Science, 23-28 (1982).
WPI66-07742F/00, date Mar. 1962, France (Eng. Abs*).
WPI84-152447/25, date Feb. 1984, Belgium (Eng. Abs*).
WPI66-00688F/00, date Jan. 1968, Great Britain (Abs*).
WPI20269 K/09, date Jun. 1981, Germany (Eng. Abs*).
WPI66-19205F/00, date Jun. 1959, Japan (Eng. Abs*).
L. Lasagna, Phenylpropanolamine: A review. (1988) (pp. 7-12; 24-25; 28-29; 138; 302; 317; 320-345).
M. Bende and L. Laurin, "Sympathomimetrics in Nasal Allergy," J. Otorhinolaryngol. Relat. Spec. 48(4):238-242), 1986.
S. Loth and M. Bende, "The Effect of Phenylpropanolamine on Nasal Secretion and Nasal Airway Resistance After Histamine Challenge in Man." Clin. Otolaryngol. 10(1):15-19 (Feb.) 1985.
Drug Facts and Comparisons, 1990 ed. Copyright 1989 published by J. B. Lippincott Co., St. Louis, Mo.
Clark Karen F.
Hulina Amy
Norwich Eaton Pharmaceuticals, Inc.
Page Thurman K.
Suter David L.
LandOfFree
Use of phenylpropanolamine as a mucus secretogogue in the upper does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of phenylpropanolamine as a mucus secretogogue in the upper , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of phenylpropanolamine as a mucus secretogogue in the upper will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1141250